Correlation Between NeuPath Health and Meta Platforms

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NeuPath Health and Meta Platforms at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuPath Health and Meta Platforms into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NeuPath Health and Meta Platforms CDR, you can compare the effects of market volatilities on NeuPath Health and Meta Platforms and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuPath Health with a short position of Meta Platforms. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuPath Health and Meta Platforms.

Diversification Opportunities for NeuPath Health and Meta Platforms

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between NeuPath and Meta is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding NeuPath Health and Meta Platforms CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Meta Platforms CDR and NeuPath Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuPath Health are associated (or correlated) with Meta Platforms. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Meta Platforms CDR has no effect on the direction of NeuPath Health i.e., NeuPath Health and Meta Platforms go up and down completely randomly.

Pair Corralation between NeuPath Health and Meta Platforms

Assuming the 90 days trading horizon NeuPath Health is expected to generate 1.6 times less return on investment than Meta Platforms. In addition to that, NeuPath Health is 2.28 times more volatile than Meta Platforms CDR. It trades about 0.03 of its total potential returns per unit of risk. Meta Platforms CDR is currently generating about 0.11 per unit of volatility. If you would invest  1,319  in Meta Platforms CDR on August 27, 2024 and sell it today you would earn a total of  1,785  from holding Meta Platforms CDR or generate 135.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NeuPath Health  vs.  Meta Platforms CDR

 Performance 
       Timeline  
NeuPath Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NeuPath Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Meta Platforms CDR 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Meta Platforms CDR are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, Meta Platforms may actually be approaching a critical reversion point that can send shares even higher in December 2024.

NeuPath Health and Meta Platforms Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NeuPath Health and Meta Platforms

The main advantage of trading using opposite NeuPath Health and Meta Platforms positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuPath Health position performs unexpectedly, Meta Platforms can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Meta Platforms will offset losses from the drop in Meta Platforms' long position.
The idea behind NeuPath Health and Meta Platforms CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas